Learn about a real-life experience with the gene mutation as well as your risk of cancer; cancer types if you have the mutation; and insurance coverage for any preventative treatment.
You thought finding out you had the BRCA1 or 2 gene mutation was tough – but now you have to tell your family members they might be at risk for it, too. Experts give advice on what to tell them when.
Dana Clark, M.S., L.C.G.C., at the Basser Center for BRCA at Penn Medicine, discusses when you’re at a high risk for BRCA gene mutations, what testing involves, and what misconceptions she commonly encounters.
Results of a recent study suggest low blood levels of vitamin D are associated with an increased risk for breast cancer in women over the age of 55.
Researchers from the Mayo Clinic in Rochester, Minnesota, discovered that an FDA-approved treatment for certain cancers of the blood may significantly reduce the growth of triple-negative breast cancers.
This week, the U.S. Food and Drug Administration (FDA) authorized 23andMe to market the first direct-to-consumer test for three specific genetic mutations known to increase the risk for breast, ovarian, and prostate cancer. Called the Personal Genome ...